BlueRiver Acquisition Corp. BLUAF
9.02
0.00
0.00%
as of 24 Sep
- Market cap
- $96.9M
- P/E
- 0.0×
Follow BLUAF
Target Price Range
Analyst price targets
Free account| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | 9.57 | 9.71 | 9.97 |
Analyst estimates 2024–2026 Powerpack |
Low Price
|
||
| — | — | — | — | — | — | — | 9.93 | 10.11 | 12.00 |
High Price
|
|||
| — | — | — | — | — | — | — | 3 | 3 | 3 |
Employees
|
|||
| — | — | — | — | — | — | — | 0 | 0 | 0 |
Revenue/Emp
|
|||
| — | — | — | — | — | — | — | — | — | — | Revenue | |||
| — | — | — | — | — | — | — | — | — | — | Gross Margin | |||
| — | — | — | — | — | — | 0 | 2 | 8 | (5) |
EBT
|
|||
| — | — | — | — | — | — | 0.00% | 0.00% | 0.00% | 0.00% |
EBT Margin
|
|||
| — | — | — | 0 | — | — | 0 | 2 | 8 | (5) |
Net Income
|
|||
| — | — | — | — | — | — | 0 | — | — | — |
Depreciation
|
|||
| — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue/Sh
|
|||
| — | — | — | — | — | — | 0.00 | 0.33 | 1.18 | (0.66) |
Earnings/Sh
|
|||
| — | — | — | — | — | — | 0.00 | (0.17) | (0.08) | (0.10) |
Cash Flow/Sh
|
|||
| — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Capex/Sh
|
|||
| — | — | — | — | — | — | 0.00 | (0.17) | (0.08) | (0.10) |
Free CF/Sh
|
|||
| — | — | — | — | — | — | 0.00 | (2.27) | (1.61) | (0.79) |
Book Value/Sh
|
|||
| — | — | — | — | — | — | 37 | 7 | 7 | 7 |
Shares
|
|||
| — | — | — | — | — | — | — | — | — | — | PE Ratio | |||
| — | — | — | — | — | — | — | — | — | — | PS Ratio | |||
| — | — | — | — | — | — | — | — | — | — | PB Ratio | |||
| — | — | — | — | — | — | — | — | — | — | EV/Sales | |||
| — | — | — | — | — | — | — | — | — | — | EV/FCF | |||
| — | — | — | — | — | — | 0 | (1) | (1) | (1) |
Op' Cash Flow
|
|||
| — | — | — | — | — | — | 0 | — | — | — |
Capex
|
|||
| — | — | — | — | — | — | 0 | (1) | (1) | (1) |
FCF
|
|||
| — | — | — | — | — | — | 0 | 0 | (1) | (5) |
Working Cap'
|
|||
| — | — | — | — | — | — | 0 | — | 0 | — |
Total Debt
|
|||
| — | — | — | — | — | — | 0 | (1) | 0 | 0 |
Net Debt
|
|||
| — | — | — | — | — | — | 0 | (16) | (12) | (6) |
Sh' Equity
|
|||
| — | — | — | — | — | — | (19.52%) | 1.61% | 2.93% | (3.38%) |
ROA
|
|||
| — | — | — | — | — | — | 0.00% | 0.00% | 0.00% | 0.00% |
ROIC
|
|||
| — | — | — | — | — | — | 0.17% | (28.80%) | (61.34%) | 61.12% |
ROE
|
|||
predictions in italic, sparklines do not include predictions
BlueRiver Acquisition Corp. peers in Shell Companies
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| PPYA Papaya Growth Opportunity Corp. I | $97.3M | 0.0× | Compare |
| PMGM Priveterra Acquisition Corp. II | $97.5M | 75.9× | Compare |
| CNDA Concord Acquisition Corp II | $95.8M | 69.4× | Compare |
| IVCAF Libity | $95.3M | 0.0× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| DSAQ Direct Selling Acquisition Corp. | $94.5M | 0.0× | Compare |
| IXAQF IX Acquisition Corp. | $99.5M | 25.6× | Compare |
| TAVI Tavia Acquisition Corp. | $94.2M | — | Compare |
| SPKL Spark I Acquisition Corporation | $100.4M | 0.0× | Compare |
BlueRiver Acquisition Corp. (BLUAF) key facts
- BlueRiver Acquisition Corp. (BLUAF) is a Shell Companies company in the Financial sector.
- As of September 24, 2026, BLUAF traded at $9.02, a market capitalization of $96.9 million.
- Return on equity was 61.1% and debt-to-equity 0.00.
BlueRiver Acquisition Corp. (BLUAF) Latest News
7 Feb
BlueRiver Acquisition Corp. Receives Commencement of Delisting Notice From NYSE American; Announces Extension of Merger Agreement
BlueRiver Acquisition Corp. received a delisting notice from NYSE American and extended its merger agreement with Spinal Stabilization Technologies, LLC. The potential delisting and extension of the merger agreement are significant events that could significantly impact the company's future and market performance.
24 Jul
Spinal Stabilization Technologies, LLC, a Leading Developer and Manufacturer of Spinal Medical Devices, to be Publicly Listed through a Proposed Business Combination with BlueRiver Acquisition Corp.
Spinal Stabilization Technologies to be publicly listed through a proposed business combination with BlueRiver Acquisition Corp. The FDA designation as a 'Breakthrough Device' and potential market opportunities are expected to significantly impact BLUA's future performance.